Φορτώνει......
Female sexual dysfunction: a focus on flibanserin
Flibanserin is the first US Food and Drug Administration (FDA)-approved option for sexual dysfunction, specifically low sexual desire. Until recently, there were no FDA-approved medication options to assist the ~40% of women affected by female sexual dysfunction (FSD). Often, patients report feeling...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Int J Womens Health |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove Medical Press
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5644557/ https://ncbi.nlm.nih.gov/pubmed/29066935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJWH.S83747 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|